New brain drug nasal spray tested in healthy men – no cure yet
NCT ID NCT07050316
First seen Mar 30, 2026 · Last updated Apr 30, 2026 · Updated 3 times
Summary
This early-stage study tested a new drug called CBT101, given as a nasal spray, in 48 healthy men. The main goal was to check if it is safe and how the body processes it. No treatment was given for any disease, so this study does not offer a cure or symptom relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROLOGIC DISEASES, GENERAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Eurofins Optimed
Gières, 38610, France
Conditions
Explore the condition pages connected to this study.